Search results
Results from the WOW.Com Content Network
In the United States, Optional Practical Training (OPT) is a period during which undergraduate and graduate students with F-1 status who have completed or have been pursuing their degrees for one academic year are permitted by the United States Citizenship and Immigration Services (USCIS) to work for one year on a student visa towards getting practical training to complement their education.
On April 2, 2008, Homeland Security Secretary Michael Chertoff announced a 17-month extension to Optional Practical Training for STEM students, as part of the H-1B Cap-Gap Regulations. [76] [77] This extension allows foreign STEM students to work in the U.S. for up to 29 months on a student visa, providing additional time to secure H-1B ...
[26] [27] [28] In the 1980s and 1990s, other specialized STEM schools, including Virginia's Thomas Jefferson High School for Science and Technology and Maryland's Montgomery Blair High School, began to produce large numbers of finalists to rival the New York schools.
Prochymal is a stem cell therapy made by Osiris Therapeutics. It is the first stem cell therapy approved by Canada. It is also the first therapy approved by Canada for acute graft-vs-host disease (GvHD). [1] Also known as remestemcel-L, Prochymal was sold to Australia-based Mesoblast in 2013 [2] at which time its brand name was changed to Ryoncil.
An interim Employment Authorization Document is an Employment Authorization Document issued to an eligible applicant when U.S. Citizenship and Immigration Services has failed to adjudicate an application within 90 days of receipt of a properly filed Employment Authorization Document application within 90 days of receipt of a properly filed Employment Authorization Document application ...
Loan type. Description. Average funding timeline. SBA 7(a) loan. 7(a) loan subtypes are backed directly by the SBA. The SBA’s turnaround time is 2 to 10 business days, but approval from your ...
Physician national interest waiver [5] is a specially designed category for physicians/doctors to work and conduct impactful research in the United States. It enables a clinical physician/doctor to adjust his/her status to a lawful permanent resident without actually demonstrating that eligible and qualified physicians are unavailable in the particular location.
Priority review vouchers are currently earned by pharmaceutical companies for the development and approval of drugs treating neglected tropical diseases, rare pediatric diseases, and "medical countermeasures" for terrorism. The voucher can be used for future drugs that could have wider indications for use, but the company is required to pay a ...